The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer

Chun-Te Wu,1,2 Yun-Ching Huang,2,3 Wen-Cheng Chen,2,4 Miao-Fen Chen2,4 1Department of Urology, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan; 2Chang Gung University, College of Medicine, Taoyuan, Taiwan; 3Department of Urology, Chang Gung Memorial Hospital at Chiayi, Chiayi, Taiwan; 4Depa...

Full description

Bibliographic Details
Main Authors: Wu CT, Huang YC, Chen WC, Chen MF
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/the-significance-of-neutrophil-to-lymphocyte-ratio-and-combined-chemor-peer-reviewed-article-CMAR
_version_ 1819078142644453376
author Wu CT
Huang YC
Chen WC
Chen MF
author_facet Wu CT
Huang YC
Chen WC
Chen MF
author_sort Wu CT
collection DOAJ
description Chun-Te Wu,1,2 Yun-Ching Huang,2,3 Wen-Cheng Chen,2,4 Miao-Fen Chen2,4 1Department of Urology, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan; 2Chang Gung University, College of Medicine, Taoyuan, Taiwan; 3Department of Urology, Chang Gung Memorial Hospital at Chiayi, Chiayi, Taiwan; 4Department of Radiation Oncology, Chang Gung Memorial Hospital at Chiayi, Chiayi, TaiwanCorrespondence: Miao-Fen ChenDepartment of Radiation Oncology, Chang Gung Memorial Hospital at Chiayi, TaiwanEmail miaofen@adm.cgmh.org.twBackground: Bladder-sparing treatment has been developed with the aim of preserving bladder function. However, considerable controversy remains regarding the effectiveness of organ preservation strategies. Accordingly, we investigated factors influencing the prognosis of muscle-invasive bladder cancer (MIBC) patients who received bladder-sparing treatment.Materials and Methods: In the study, we retrospectively reviewed 193 patients who were newly diagnosed with MIBC and received bladder-sparing treatment from 2006 to 2013 in our hospital.Results: The 5-year overall survival, progression-free survival (PFS) and bladder-preservation survival rates after diagnosis were 64.7%, 52.1%, and 64%, respectively. The presence of hydronephrosis, advanced stage and not achieving complete response were associated with a marked reduction in PFS. Treatment with an adequate dose of combined chemoradiotherapy (CCRT) (chemotherapy ≥ 2 cycles combined with radiotherapy dose ≥ 56Gy) significantly improved the complete response (CR), 5-year bladder-preservation survival, and PFS rates, particularly for patients with good performance status. The 5-year bladder-preservation survival rates for CR and non-CR patients were 75%, and 21%, respectively. Furthermore, higher pre-treatment neutrophil-to-lymphocyte ratio (NLR) (≥ 3) and lower hemoglobin (≤ 12) were significantly associated with lower CR rate, increased risk of loco-regional recurrence and reduced bladder-preservation survival rate. Multivariable Cox regression analysis based on different co-variables showed that pretreatment NLR was an independent prognostic factor for PFS when MIBC patients were stratified by clinical stage and the doses of CCRT.Conclusion: In MIBC patients with bladder-sparing treatment, adequate doses of CCRT and low NLR were found to be correlated with better PFS. We suggest the use of NLR as a clinical biomarker for the prognosis of MIBC and guidance of treatment decisions.Keywords: MIBC, bladder-sparing, radiotherapy, recurrence, NLR
first_indexed 2024-12-21T19:08:24Z
format Article
id doaj.art-5506ca2e92ed4991a144cc868e7550e8
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-21T19:08:24Z
publishDate 2020-12-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-5506ca2e92ed4991a144cc868e7550e82022-12-21T18:53:16ZengDove Medical PressCancer Management and Research1179-13222020-12-01Volume 12131251313560595The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder CancerWu CTHuang YCChen WCChen MFChun-Te Wu,1,2 Yun-Ching Huang,2,3 Wen-Cheng Chen,2,4 Miao-Fen Chen2,4 1Department of Urology, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan; 2Chang Gung University, College of Medicine, Taoyuan, Taiwan; 3Department of Urology, Chang Gung Memorial Hospital at Chiayi, Chiayi, Taiwan; 4Department of Radiation Oncology, Chang Gung Memorial Hospital at Chiayi, Chiayi, TaiwanCorrespondence: Miao-Fen ChenDepartment of Radiation Oncology, Chang Gung Memorial Hospital at Chiayi, TaiwanEmail miaofen@adm.cgmh.org.twBackground: Bladder-sparing treatment has been developed with the aim of preserving bladder function. However, considerable controversy remains regarding the effectiveness of organ preservation strategies. Accordingly, we investigated factors influencing the prognosis of muscle-invasive bladder cancer (MIBC) patients who received bladder-sparing treatment.Materials and Methods: In the study, we retrospectively reviewed 193 patients who were newly diagnosed with MIBC and received bladder-sparing treatment from 2006 to 2013 in our hospital.Results: The 5-year overall survival, progression-free survival (PFS) and bladder-preservation survival rates after diagnosis were 64.7%, 52.1%, and 64%, respectively. The presence of hydronephrosis, advanced stage and not achieving complete response were associated with a marked reduction in PFS. Treatment with an adequate dose of combined chemoradiotherapy (CCRT) (chemotherapy ≥ 2 cycles combined with radiotherapy dose ≥ 56Gy) significantly improved the complete response (CR), 5-year bladder-preservation survival, and PFS rates, particularly for patients with good performance status. The 5-year bladder-preservation survival rates for CR and non-CR patients were 75%, and 21%, respectively. Furthermore, higher pre-treatment neutrophil-to-lymphocyte ratio (NLR) (≥ 3) and lower hemoglobin (≤ 12) were significantly associated with lower CR rate, increased risk of loco-regional recurrence and reduced bladder-preservation survival rate. Multivariable Cox regression analysis based on different co-variables showed that pretreatment NLR was an independent prognostic factor for PFS when MIBC patients were stratified by clinical stage and the doses of CCRT.Conclusion: In MIBC patients with bladder-sparing treatment, adequate doses of CCRT and low NLR were found to be correlated with better PFS. We suggest the use of NLR as a clinical biomarker for the prognosis of MIBC and guidance of treatment decisions.Keywords: MIBC, bladder-sparing, radiotherapy, recurrence, NLRhttps://www.dovepress.com/the-significance-of-neutrophil-to-lymphocyte-ratio-and-combined-chemor-peer-reviewed-article-CMARmibcbladder-sparingradiotherapyrecurrencenlr
spellingShingle Wu CT
Huang YC
Chen WC
Chen MF
The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
Cancer Management and Research
mibc
bladder-sparing
radiotherapy
recurrence
nlr
title The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
title_full The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
title_fullStr The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
title_full_unstemmed The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
title_short The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
title_sort significance of neutrophil to lymphocyte ratio and combined chemoradiotherapy in patients undergoing bladder preservation therapy for muscle invasive bladder cancer
topic mibc
bladder-sparing
radiotherapy
recurrence
nlr
url https://www.dovepress.com/the-significance-of-neutrophil-to-lymphocyte-ratio-and-combined-chemor-peer-reviewed-article-CMAR
work_keys_str_mv AT wuct thesignificanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer
AT huangyc thesignificanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer
AT chenwc thesignificanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer
AT chenmf thesignificanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer
AT wuct significanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer
AT huangyc significanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer
AT chenwc significanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer
AT chenmf significanceofneutrophiltolymphocyteratioandcombinedchemoradiotherapyinpatientsundergoingbladderpreservationtherapyformuscleinvasivebladdercancer